Results From Lung Transplant Drug Therapy Trial Reveal Expected But Appealing Findings
April 20, 2012 11:12 ET
|
The International Society for Heart and Lung Transplantation
PRAGUE, Czech Republic, April 20, 2012 (GLOBE NEWSWIRE) -- Results of a three-year international study of drug therapy for lung transplant patients will be presented today by Allan Glanville, M.D.,...
International Experts Address Challenges of Drug-Resistant Infection in Heart and Lung Transplant Population
April 20, 2012 07:15 ET
|
The International Society for Heart and Lung Transplantation
PRAGUE, Czech Republic, April 20, 2012 (GLOBE NEWSWIRE) -- Drug-resistant infections are an increasing worldwide problem contributing to significant mortality and morbidity in heart and lung...
New Data Released At ISHLT Meeting May Impact Treatment for Patients With Pulmonary Arterial Hypertension
April 19, 2012 09:03 ET
|
The International Society for Heart and Lung Transplantation
PRAGUE, Czech Republic, April 19, 2012 (GLOBE NEWSWIRE) -- An initial report from the EPITOME-1 (Epoprostenol for Injection in Pulmonary Arterial Hypertension) study of a new formulation of the drug...
INTERMACS Data Shows Progress Using MCS Devices in Destination Therapy as a Permanent Treatment Option for Heart Failure
April 18, 2012 11:14 ET
|
The International Society for Heart and Lung Transplantation
PRAGUE, Czech Republic, April 18, 2012 (GLOBE NEWSWIRE) -- Today researchers will report initial findings of a post-FDA-approval study using Left Ventricular Assist Devices as destination therapy for...